Anzueto, Antonio
Cohen, Mark
Echazarreta, Andres L.
Elassal, Gehan
Godoy, Irma
Paramo, Rafael
Sayiner, Abdullah
Torres-Duque, Carlos A.
Acharya, Sudeep
Aggarwal, Bhumika
Erkus, Hakan
Levy, Gur
Funding for this research was provided by:
GSK
Article History
Received: 6 October 2023
Accepted: 20 November 2023
First Online: 19 December 2023
Declarations
:
: Antonio Anzueto received funding for this study from GSK and consulting fees in personal capacity from GSK, AstraZeneca, Verona Pharma, Sanofi, Boehringer Ingelheim, Viatrix. Mark Cohen reports travel support and payment for lectures and presentations from AstraZeneca, Boehringer Ingelheim, GSK, Luminova and Novartis; payment for participation in advisory boards of AstraZeneca, Boehringer Ingelheim; and has participated in an unpaid capacity in committees for the Asoaciación Latinoamericana del Tórax (ALAT), and the American Thoracic Society (ATS). Andres L Echazarreta received funding from GSK for this study, payment for lectures, and meeting attendance from AstraZeneca, Kamada/Tuteur, Grifols; payment for participation in advisory boards from GSK, AstraZeneca; and payment for expert testimony from AstraZeneca. Gehan Elassal reports receiving honoraria from GSK, AstraZeneca, and Sanofi for lectures. Irma Godoy received funding from Sanofi for participation in advisory board and received honoraria from MSD for lecture presentation. Rafael Paramo reports receiving financial support to attend conferences and medical events from GSK, AstraZeneca, Chiesi, Novartis and Boehringer Ingelheim; consulting fees from GSK, Chiesi; and payment for participation in advisory board of GSK; and has participated in an unpaid capacity in committees for the Sociedad Queretana de neumologia y Cirugia de Torax AC and the Sociedad Mexicana de neumologia y Cirugia de Torax AC. Abdullah Sayiner received consulting fees or honoraria (for lectures and educational events) from GSK, Abdi Ibrahim, Pfizer, and Abbott. Carlos A Torres-Duque has received payment as advisory board participant or speaker from AstraZeneca, Boehringer Ingelheim, GSK, Novartis, and Sanofi-Aventis; has participated in clinical trials from AstraZeneca, Novartis, and Sanofi-Aventis; has received unrestricted grants for investigator-initiated studies at Fundacion Neumologica Colombiana from AstraZeneca, Boehringer Ingelheim, GSK, Grifols and Novartis. Sudeep Acharya is an employee of GSK and holds shares in GSK. Bhumika Aggarwal is an employee of GSK and holds shares in GSK. Hakan Erkus is an employee of GSK and holds shares in GSK. Gur Levy is an employee of GSK and holds shares in GSK.
: As this is a non-interventional physician survey based on a Delphi process gathering expert opinions without patient participation, no ethical approval was required for this study. Rights involved in the Delphi study were explained at the survey onset, and by returning the questionnaires, the participants gave their consent to take part in the study. These measures support the ethical principles of respect and the right of self-determination and of obtaining an informed consent.